tiprankstipranks
Advertisement
Advertisement
3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026
PremiumMarket News3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026
29d ago
Pharming price target lowered to $40 from $41 at Oppenheimer
Premium
The Fly
Pharming price target lowered to $40 from $41 at Oppenheimer
29d ago
Pharming reports Q1 EPS 1c, consensus 0c
Premium
The Fly
Pharming reports Q1 EPS 1c, consensus 0c
1M ago
Pharming initiated with a Buy at Canaccord on growth potential
PremiumThe FlyPharming initiated with a Buy at Canaccord on growth potential
2M ago
Pharming initiated with a Buy at Canaccord
Premium
The Fly
Pharming initiated with a Buy at Canaccord
2M ago
Pharming Group Files 2025 Annual Report and Form 20-F
Premium
Company Announcements
Pharming Group Files 2025 Annual Report and Form 20-F
2M ago
Pharming: Solid Execution, Resilient Revenue, and Joenja Growth Support Buy Rating Ahead of Key Leniolisib Catalysts
PremiumRatingsPharming: Solid Execution, Resilient Revenue, and Joenja Growth Support Buy Rating Ahead of Key Leniolisib Catalysts
3M ago
Pharming Group Posts Strong 2025 Growth, Turns Profitable and Lifts 2026 Outlook
Premium
Company Announcements
Pharming Group Posts Strong 2025 Growth, Turns Profitable and Lifts 2026 Outlook
3M ago
PHAR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PHAR Upcoming Earnings Report: What to Expect?
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100